Home/Filings/4/0001013606-19-000171
4//SEC Filing

Fecho Jeff 4

Accession 0001013606-19-000171

CIK 0001013606other

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 4:31 PM ET

Size

8.1 KB

Accession

0001013606-19-000171

Insider Transaction Report

Form 4
Period: 2019-09-27
Fecho Jeff
Chief Quality Officer
Transactions
  • Disposition to Issuer

    Option to Purchase

    2019-09-276,7890 total
    Exercise: $56.70From: 2019-06-25Exp: 2028-06-25Common Stock (6,789 underlying)
  • Award

    Option to Purchase

    2019-09-27+2,2632,263 total
    Exercise: $4.71From: 2020-09-10Exp: 2026-09-10Common Stock (2,263 underlying)
Footnotes (3)
  • [F1]Thirty-three percent of the options vested upon one year of service and the remaining balance continued to vest in equal monthly installments thereafter.
  • [F2]The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, an option for 6,789 shares of common stock granted to the reporting person on June 25, 2018. In exchange, the reporting person received a new stock option, for 2,263 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019.
  • [F3]The options vest in three equal annual installments over a three-year period commencing on September 10, 2019.

Issuer

ENDOLOGIX INC /DE/

CIK 0001013606

Entity typeother

Related Parties

1
  • filerCIK 0001539783

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:31 PM ET
Size
8.1 KB